S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.16%) $0.928
USD/NOK
(0.29%) $10.87
USD/GBP
(0.01%) $0.792
USD/RUB
(0.02%) $92.60

Realtime updates for Cue Biopharma Inc [CUE]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Upcoming Earnings Alert

4 days till quarter result
(bmo 2024-04-02)

Expected move: +/- 9.08%

Last Updated28 Mar 2024 @ 16:00

2.72% $ 1.890

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders...

Stats
Today's Volume 187 949
Average Volume 272 109
Market Cap 85.28M
EPS $-0.240 ( 2023-11-09 )
Next earnings date ( $-0.290 ) 2024-04-02
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.570
ATR14 $0.00600 (0.31%)
Insider Trading
Date Person Action Amount type
2024-03-06 Sandercock Colin Buy 175 000 Stock Option (right to buy)
2024-03-06 Suri Anish Buy 300 000 Stock Option (right to buy)
2024-03-06 Millar Kerri-ann Buy 250 000 Stock Option (right to buy)
2024-03-06 Passeri Daniel R Buy 400 000 Stock Option (right to buy)
2024-03-06 Levisetti Matteo Buy 260 000 Stock Option (right to buy)
INSIDER POWER
97.37
Last 98 transactions
Buy: 5 498 246 | Sell: 593 660

Volume Correlation

Long: 0.04 (neutral)
Short: 0.82 (strong)
Signal:(59.257) Same movement expected

Cue Biopharma Inc Correlation

10 Most Positive Correlations
NLTX0.886
RPHM0.872
RNAZ0.843
SGTX0.843
ACLX0.842
ADMP0.842
NISN0.834
SDIG0.833
RMRM0.832
VCXA0.828
10 Most Negative Correlations
TCBS-0.877
CDW-0.875
MYNZ-0.87
RGP-0.865
RBBN-0.863
PTSI-0.862
CASS-0.858
HOFT-0.858
LSAK-0.846
FFBW-0.844

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cue Biopharma Inc Correlation - Currency/Commodity

The country flag 0.25
( neutral )
The country flag 0.32
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.33
( neutral )

Cue Biopharma Inc Financials

Annual 2022
Revenue: $1.25M
Gross Profit: $-560 828 (-45.04 %)
EPS: $-1.480
Q3 2023
Revenue: $2.10M
Gross Profit: $1.24M (59.19 %)
EPS: $-0.240
Q2 2023
Revenue: $1.38M
Gross Profit: $534 000 (38.64 %)
EPS: $-0.290
Q1 2023
Revenue: $187 000
Gross Profit: $-693 000 (-370.59 %)
EPS: $-0.300

Financial Reports:

No articles found.

Cue Biopharma Inc

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target and activate antigen-specific T cells for human papilloma virus-driven cancers. The company offers CUE-102, a fusion protein biologic to target and activate antigen-specific T cells to fight cancers; CUE-103 a CUE-100 series Immuno-STAT targeting the KRAS G12V mutation, including colorectal carcinoma, lung cancer, and pancreatic cancer; CUE-200 that focuses on cell surface receptors, including CD80 and/or 4-1BBL to address T cell exhaustion associated with chronic infections; and CUE-300 and CUE-400 framework to target various autoimmune diseases. Cue Biopharma, Inc. has collaboration agreements with Merck Sharp & Dohme Corp. for the research and development of its proprietary biologics that target various autoimmune disease indications; LG Chem Life Sciences for the development of Immuno-STATs focused on the field of oncology; and Albert Einstein College of Medicine. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators